Trial intelligence / Profile preview

Melatonin for Sleep Quality in IBD Patients in Remission

NCT07737665Phase 4Recruiting

Sponsor
Mahidol University
Start
Apr 2025
Primary completion
Apr 2027
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in sleep disorders comparing Melatonin with Placebo (2 arms). Primary endpoint: Pittsburgh Sleep Quality Index at 12 weeks. Started Apr 2025; status: recruiting.

02

Drugs

melatonin
03

Conditions

sleep disorders

Beyond the preview

Go deeper on NCT07737665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07737665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call